2018
$119M
from 8 investors over 8 rounds
Alladapt Immunotherapeutics, Inc. raised $50M on August 30, 2022
Investors: Hercules Capital, Inc.
Alladapt Immunotherapeutics, Inc. raised $119M on June 22, 2022
Investors: Red Tree Venture Capital, Patient Square Capital, Gurnet Point Capital and WestRiver Group
Alladapt Immunotherapeutics, Inc. raised $60M on February 20, 2020
Investors: TRB Advisors LP, Camino Partners (formerly Equilibra) and Gurnet Point Capital